Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Aug 21:11:427-438.
doi: 10.2147/DMSO.S171365. eCollection 2018.

Medications that cause weight gain and alternatives in Canada: a narrative review

Sean Wharton  1   2 , Lilian Raiber  1 , Kristin J Serodio  1 , Jasmine Lee  1 , Rebecca Ag Christensen  1
Affiliations
Review

Medications that cause weight gain and alternatives in Canada: a narrative review

Sean Wharton et al. Diabetes Metab Syndr Obes. .

Abstract

Background: The cause of the obesity epidemic is multifactorial, but may, in part, be related to medication-induced weight gain. While clinicians may strive to do their best to select pharmacotherapy(ies) that has the least negative impact on weight, the literature regarding the weight effects of medication is often limited and devoid of alternative therapies.

Results: Antipsychotics, antidepressants, antihyperglycemics, antihypertensives and corticosteroids all contain medications that were associated with significant weight gain. However, there are several medication alternatives within the majority of these classes associated with weight neutral or even weight loss effects. Further, while not all of the classes of medication examined in this review have weight-favorable alternatives, there exist many other tools to mitigate weight gain associated with medication use, such as changes in dosing, medication delivery or the use of adjunctive therapies.

Conclusion: Medication-induced weight gain can be frustrating for both the patient and the clinician. As the use of pharmaceuticals continues to increase, it is pertinent for clinicians to consider the weight effects of medications prior to prescribing or in the course of treatment. In the case where it is not feasible to make changes to medication, adjunctive therapies should be considered.

Keywords: adjunctive therapy; adverse effects of medications; obesity; weight gain; weight loss; weight neutral.

PubMed Disclaimer

Conflict of interest statement

Disclosure SW is the Medical Director of the Wharton Medical Clinic and maintains privileges at Toronto East General Hospital and Hamilton Health Sciences. SW has previously received grants from CIHR and Mitacs, and has payment from Novo Nordisk, Eli Lilly, Janssen and Astra Zeneca for advisory work. SW and RAGC are currently working with Novo Nordisk for the completion of pharmaceutical manuscript(s). RAGC is also the Research Coordinator at the Wharton Medical Clinic. The authors report no other conflicts of interest in this work.

References

    1. Rotermann M, Sanmartin C, Hennessy D, Arthur M. Prescription medication use by Canadians aged 6 to 79. Health Rep. 2014;25:3–9. - PubMed
    1. Centre for Disease Control and Prevention Staff Therapeutic Drug Use (2017) [Accessed January, 2018]. Available from: https://www.cdc.gov/nchs/fastats/drug-use-therapeutic.htm.
    1. Leslie WS, Hankey CR, Lean MEJ. Weight gain as an adverse effect of some commonly prescribed drugs: a systematic review. QMJ. 2007;100:395–404. - PubMed
    1. Verhaegen AA, van Gaal LF. Drug-induced obesity and its metabolic consequences: a review with a focus on mechanisms and possible therapeutic options. J Endocrinol Invest. 2017;40:1165–1174. - PubMed
    1. Domecq JP, Prutsky G, Leppin A, et al. Drugs commonly associated with weight change: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2015;100:363–370. - PMC - PubMed